A buyer bought in pre CSPA 250,000 shares at .44. That’s more volume than what was traded before 4pm. Had his order at .43 and moved it up
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025